1. Implementation of a surgical site infection prevention bundle in gynecologic oncology patients: An enhanced recovery after surgery initiative.
- Author
-
Ejaredar, Maede, Ruzycki, Shannon M., Glazer, Tali Sara, Trudeau, Pat, Jim, Brent, Nelson, Gregg, and Cameron, Anna
- Subjects
- *
SURGICAL site infections , *ENHANCED recovery after surgery protocol , *GYNECOLOGIC oncology , *INFECTION prevention , *GYNECOLOGIC care , *CANCER patients , *GYNECOLOGIC surgery - Abstract
To evaluate the clinical outcomes pre- and post-implementation of an evidence-informed surgical site infection prevention bundle (SSIPB) in gynecologic oncology patients within an Enhanced Recovery After Surgery (ERAS) care pathway. Patients undergoing laparotomy for a gynecologic oncology surgery between January–June 2017 (pre-SSIPB) and between January 2018–December 2020 (post-SSIPB) were compared using t -tests and chi-square. Patient characteristics, surgical factors, and ERAS process measures and outcomes were abstracted from the ERAS® Interactive Audit System (EIAS). The primary outcomes were incidence of surgical site infections (SSI) during post-operative hospital admission and at 30-days post-surgery. Secondary outcomes included total postoperative infections, length of stay, and any surgical complications. Multivariate models were used to adjust for potential confounding factors. Patient and surgical characteristics were similar in the pre- and post-implementation periods. Evaluation of implementation suggested that preoperative and intraoperative components of the intervention were most consistently used. Infectious complications within 30 days of surgery decreased from 42.1% to 24.4% after implementation of the SSIPB (p < 0.001), including reductions in wound infections (17.0% to 10.8%, p = 0.02), urinary tract infections (UTI) (12.7% to 4.5%, p < 0.001), and intra-abdominal abscesses (5.4% to 2.5%, p = 0.05). These reductions were associated with a decrease in median length of stay from 3 to 2 days (p = 0.001). In multivariate analysis, these SSI reductions remained statistically significant after adjustment for potential confounders. Implementation of SSIPB was associated with a reduction in SSIs and infectious complications, as well as a shorter length of stay in gynecologic oncology patients. [Display omitted] • A Surgical Site Infection Prevention Bundle (SSIBP) requires coordination between healthcare providers. • Evaluating the implementation of a SSIBP in gynecologic oncology patients is challenging. • SSIPB Implementation is associated with improved surgical outcomes: shorter length of stay and fewer infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF